Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

Sophy Denker; Aitomi Bittner; Mareike Frick; Julia Kase; Jörg Hoffmann; Corinna Trenker; Ulrich Keller; Christian Bogner; Andreas Hüttmann; Clemens Schmitt; et al.

doi:10.1080/10428194.2021.1964024

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

Sophy Denker
, Aitomi Bittner
, Mareike Frick
, Julia Kase
, Jörg Hoffmann
, Corinna Trenker
, Ulrich Keller
, Christian Bogner
, Andreas Hüttmann
, Clemens Schmitt
, et al.

Department of Internal Medicine 3 - Hematology and Internal Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	84-92
Number of pages	9
Journal	Leukemia and Lymphoma
Volume	63
Issue number	1
DOIs	https://doi.org/10.1080/10428194.2021.1964024
Publication status	Published - Aug 2021

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2021.1964024

Cite this

Denker, S., Bittner, A., Frick, M., Kase, J., Hoffmann, J., Trenker, C., Keller, U., Bogner, C., Hüttmann, A., Schmitt, C., & et al. (2021). Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals. Leukemia and Lymphoma, 63(1), 84-92. https://doi.org/10.1080/10428194.2021.1964024

@article{322642b618634a409d8b93ed97a44be9,

title = "Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals",

author = "Sophy Denker and Aitomi Bittner and Mareike Frick and Julia Kase and J{\"o}rg Hoffmann and Corinna Trenker and Ulrich Keller and Christian Bogner and Andreas H{\"u}ttmann and Clemens Schmitt and \{et al.\}",

year = "2021",

month = aug,

doi = "10.1080/10428194.2021.1964024",

language = "English",

volume = "63",

pages = "84--92",

journal = "Leukemia and Lymphoma",

issn = "1029-2403",

number = "1",

}

Denker, S, Bittner, A, Frick, M, Kase, J, Hoffmann, J, Trenker, C, Keller, U, Bogner, C, Hüttmann, A, Schmitt, C & et al. 2021, 'Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals', Leukemia and Lymphoma, vol. 63, no. 1, pp. 84-92. https://doi.org/10.1080/10428194.2021.1964024

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals. / Denker, Sophy; Bittner, Aitomi; Frick, Mareike et al.
In: Leukemia and Lymphoma, Vol. 63, No. 1, 08.2021, p. 84-92.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

AU - Denker, Sophy

AU - Bittner, Aitomi

AU - Frick, Mareike

AU - Kase, Julia

AU - Hoffmann, Jörg

AU - Trenker, Corinna

AU - Keller, Ulrich

AU - Bogner, Christian

AU - Hüttmann, Andreas

AU - Schmitt, Clemens

AU - et al., null

PY - 2021/8

Y1 - 2021/8

UR - https://www.scopus.com/pages/publications/85113816561

U2 - 10.1080/10428194.2021.1964024

DO - 10.1080/10428194.2021.1964024

M3 - Article

SN - 1029-2403

VL - 63

SP - 84

EP - 92

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 1

ER -

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this